autologous anti-cd19 car-t cells caba-201 vs ultomiris
| autologous anti-cd19 car-t cells caba-201 | ultomiris | |
|---|---|---|
| Developers | 0 | 1 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Autologous Anti-CD19 CAR-T Cells CABA-201 | ravulizumab-cwvz |
| autologous anti-cd19 car-t cells caba-201 | ultomiris | |
|---|---|---|
| Developers | 0 | 1 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Autologous Anti-CD19 CAR-T Cells CABA-201 | ravulizumab-cwvz |